Brentuximab Vedotin and Rituximab with Reduced Toxicity Chemotherapy in Children, Adolescents and Young Adults with Newly Diagnosed Hodgkin Lymphoma

Hochberg J.; Basso J.; Klejmont L.; Flower A.; Bortfeld K.; Harrison L.; Shi Q.; Islam H.; Gerard P.; Voss S.; Cairo M.

首页> 外文期刊>Klinische Paediatrie >Brentuximab Vedotin and Rituximab with Reduced Toxicity Chemotherapy in Children, Adolescents and Young Adults with Newly Diagnosed Hodgkin Lymphoma

【24h】

Brentuximab Vedotin and Rituximab with Reduced Toxicity Chemotherapy in Children, Adolescents and Young Adults with Newly Diagnosed Hodgkin Lymphoma

机译：Brentuximab vedotin和Rituximab与新诊断出霍格金淋巴瘤的儿童，青少年和年轻成人减少毒性化疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Klinische Paediatrie》 |2020年第2期|共1页
作者
Hochberg J.; Basso J.; Klejmont L.; Flower A.; Bortfeld K.; Harrison L.; Shi Q.; Islam H.; Gerard P.; Voss S.; Cairo M.;
展开▼
作者单位

New York Med Coll Pediat Valhalla NY 10595 USA;

New York Med Coll Pediat Valhalla NY 10595 USA;

New York Med Coll Pediat Valhalla NY 10595 USA;

New York Med Coll Pediat Valhalla NY 10595 USA;

New York Med Coll Pediat Valhalla NY 10595 USA;

New York Med Coll Pediat Valhalla NY 10595 USA;

New York Med Coll Stat Valhalla NY 10595 USA;

New York Med Coll Pathol Valhalla NY 10595 USA;

New York Med Coll Radiol Valhalla NY 10595 USA;

Boston Childrens Hosp Radiol Boston MA USA;

New York Med Coll Pediat Valhalla NY 10595 USA;

展开▼
收录信息
原文格式 PDF
正文语种 ger
中图分类儿科学;
关键词
入库时间 2022-08-20 04:17:34

相似文献

外文文献
中文文献
专利

1. Brentuximab Vedotin and Rituximab with Reduced Toxicity Chemotherapy in Children, Adolescents and Young Adults with Newly Diagnosed Hodgkin Lymphoma [J] . Hochberg J., Basso J., Klejmont L., Klinische Paediatrie . 2020,第2期

机译：Brentuximab vedotin和Rituximab与新诊断出霍格金淋巴瘤的儿童，青少年和年轻成人减少毒性化疗
2. The addition of bendamustine to brentuximab vedotin leads to improved rates of complete metabolic remission in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma: a retrospective single-centre series [J] . McMillan Annabel, ONeill Aideen T., Townsend William, British Journal of Haematology . 2021,第3期

机译：向Brentuximab Vedotin添加Bendamustine导致儿童，青少年和年轻成人的完全代谢缓解率提高，具有复发和难治性古典霍奇金淋巴瘤：回顾性单中心系列
3. Brentuximab vedotin plus bendamustine in relapsed and refractory classical Hodgkin lymphoma in children, adolescents and young adults: a single centre experience [J] . McMillan A., ONeill A. T., Humphries P., Klinische Paediatrie . 2020,第2期

机译：Brentuximab Vedotin Plus Bendamustine在儿童，青少年和年轻人中复发和难治古典霍奇金淋巴瘤：单一中心经验
4. Mobi-Expo: Using software modified smartphortes to characterize mobile phone use in children, adolescents, and young adults [C] . Mobi-Expo study group Annual conference of the International Society of Exposure Science . 2014

机译：Mobi-Expo：使用经过软件修改的智能手机来表征儿童，青少年和年轻人中的手机使用情况
5. Estimation of G-CSF effectiveness in reducing neutropenia hospitalization among Non-Hodgkin's Lymphoma (NHL) patients treated with anthracycline-based chemotherapy. [D] . Pan, Xiaoyun. 2010

机译：估计G-CSF在以蒽环类为基础的化学疗法治疗的非霍奇金淋巴瘤（NHL）患者中减少中性粒细胞减少症住院的有效性。
6. Cost-Effectiveness Analysis of Brentuximab Vedotin With Chemotherapy in Newly Diagnosed Stage III and IV Hodgkin Lymphoma [O] . Scott F. Huntington, Gottfried von Keudell, Amy J. Davidoff, -1

机译：Brentuximab Vedotin联合化疗在新诊断的III和IV期霍奇金淋巴瘤中的成本效果分析
7. Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma [O] . Radhakrishnan Ramchandren, Ranjana H. Advani, Stephen M. Ansell, 2019

机译：Brentuximab Vedotin加上北美患者的化疗，具有新诊断的阶段III或IV霍奇金淋巴瘤

Brentuximab Vedotin and Rituximab with Reduced Toxicity Chemotherapy in Children, Adolescents and Young Adults with Newly Diagnosed Hodgkin Lymphoma

著录项

相似文献

相关主题

期刊订阅